Seaport Therapeutics reports Q1 2026 financial results

Filed June 8, 2026 · Period ending June 8, 2026 · ~1 min read

Key Changes

• medium

  Company announced financial results for the three months ended March 31, 2026 via press release. Specific financial metrics and performance data are contained in the attached exhibit.

  Item 2.02 verify on EDGAR →
• low

  This is a routine quarterly earnings disclosure filed under Item 2.02 (Results of Operations and Financial Condition). The 8-K itself contains no financial details beyond the announcement.

  8-K: Earnings verify on EDGAR →